STORM Therapeutics Presents Breakthrough Data at RNA Epigenetics Conference.
Cambridge, UK. 18 September 2019. STORM Therapeutics, the biotechnology company focused on the discovery of small molecule therapies modulating RNA epigenetics, announced today that Oliver Rausch, Chief Scientific Officer of STORM Therapeutics, will present first of its kind data on targeting RNA modifying enzymes for cancer treatment at its inaugural “RNA Epigenetics in Human […]
STORM Therapeutics Presents Breakthrough Data at RNA Epigenetics Conference. Read More »